Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501600PMID: 30000660
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 72559-06-9
Drug Levels and Effects
Summary of Use during Lactation
The amount of rifabutin in milk is insufficient to treat tuberculosis in the breastfed infant. The Centers for Disease Control and Prevention and other professional organizations state that breastfeeding should not be discouraged in women taking rifabutin.[1-3] Monitor the infant for signs of liver toxicity. Breastmilk may be stained a brown-orange color.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603–62. [PubMed: 12588714]
- 2.
- Anon. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52:1–77. [PubMed: 12836625]
- 3.
- Bartlett JG. Guidelines section. Infect Dis Clin Pract. 2002;11:467–71. [CrossRef]
Substance Identification
Substance Name
Rifabutin
CAS Registry Number
72559-06-9
Drug Class
Breast Feeding
Milk, Human
Anti-infective Agents
Antitubercular Agents
Leprostatic Agents
Rifamycins
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Rifampin.[Drugs and Lactation Database (...]Review Rifampin.. Drugs and Lactation Database (LactMed®). 2006
- Review Rifapentine.[Drugs and Lactation Database (...]Review Rifapentine.. Drugs and Lactation Database (LactMed®). 2006
- Review Rifamycin.[Drugs and Lactation Database (...]Review Rifamycin.. Drugs and Lactation Database (LactMed®). 2006
- Review Pyrazinamide.[Drugs and Lactation Database (...]Review Pyrazinamide.. Drugs and Lactation Database (LactMed®). 2006
- Review Norfloxacin.[Drugs and Lactation Database (...]Review Norfloxacin.. Drugs and Lactation Database (LactMed®). 2006
- Rifabutin - Drugs and Lactation Database (LactMed®)Rifabutin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...